Impact of mutations in epigenetic modifiers in acute myeloid leukemia: A systematic review and meta-analysis
This is a systematic review and meta-analysis evaluating the prognostic significance of epigenetic mutations on the overall survival (OS) in Acute Myeloid Leukemia (AML). We searched for studies evaluating epigenetic mutations in AML (up to November 2018) in PubMed, Trip database and Cochrane librar...
Main Authors: | Fatma Al-Bulushi, Rahma Al-Riyami, Zainab Al-Housni, Bushra Al-Abri, Murtadha Al-Khabori |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.967657/full |
Similar Items
-
Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
by: Xiaoyan Liu, et al.
Published: (2019-10-01) -
ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia‐related changes and normal karyotype
by: Concepción Prats‐Martín, et al.
Published: (2020-06-01) -
The current knowledge on ASXL1-mutated acute myeloid leukemia
by: Marta Andrzejewska, et al.
Published: (2022-02-01) -
Clinical characteristics and prognosis analysis of patients with de novo ASXL1‐mutated AML treated with the C‐HUNAN‐AML‐15 protocol: A multicenter study by the South China Pediatric AML Collaborative Group
by: Minhui Zeng, et al.
Published: (2023-06-01) -
Expression profiling of some Acute Myeloid Leukemia - associated markers to assess their diagnostic / prognostic potential
by: Nahla O. Mousa, et al.
Published: (2021-01-01)